Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA485974
Max Phase: Preclinical
Molecular Formula: C17H14ClN5O2S
Molecular Weight: 387.85
Molecule Type: Small molecule
Associated Items:
ID: ALA485974
Max Phase: Preclinical
Molecular Formula: C17H14ClN5O2S
Molecular Weight: 387.85
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: Cc1ccc(N2c3ccc(Cl)cc3S(=O)(=O)c3c(N)nc(N)nc32)cc1
Standard InChI: InChI=1S/C17H14ClN5O2S/c1-9-2-5-11(6-3-9)23-12-7-4-10(18)8-13(12)26(24,25)14-15(19)21-17(20)22-16(14)23/h2-8H,1H3,(H4,19,20,21,22)
Standard InChI Key: DXYFPPMDWUNMAK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 387.85 | Molecular Weight (Monoisotopic): 387.0557 | AlogP: 3.22 | #Rotatable Bonds: 1 |
Polar Surface Area: 115.20 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 2.26 | CX LogP: 3.68 | CX LogD: 3.68 |
Aromatic Rings: 3 | Heavy Atoms: 26 | QED Weighted: 0.51 | Np Likeness Score: -1.30 |
1. Barazarte A, Lobo G, Gamboa N, Rodrigues JR, Capparelli MV, Alvarez-Larena A, López SE, Charris JE.. (2009) Synthesis and antimalarial activity of pyrazolo and pyrimido benzothiazine dioxide derivatives., 44 (3): [PMID:18835067] [10.1016/j.ejmech.2008.08.005] |
Source(1):